by Irene Anton Sales, Nanoparticles and Nanocomposites (NN) group, ICMAB, CSIC
Date: Thursday, 3 June 2021
Time: 10 am
Venue: ICMAB Seminar Room "Carles Miravitlles" and online session by Zoom. Register here to attend by Zoom.
Abstract: Biomaterials are gradually transitioning from inert structural supports to biomimetic and bioactive platforms placed at the forefront of healthcare research. Such biomaterials are increasingly being derived from nature, expecting to offer more sustainable and biointeractive solutions. In parallel, biotechnological advances enable the manufacturing of medical-use substances in an animal and donor independent manner providing new perspectives to the multi-sectorial field of biomaterials. The recent commercialization of nanocellulose patches synthesized by bacteria as wound dressings is illustrative of this paradigm shift. Despite such a breakthrough, the potential of bacterial nanocellulose in healthcare remains underexploited as this biopolymer exhibits a unique combination of properties and almost unlimited design possibilities.
In this thesis, I investigated innovative medical uses of bacterial nanocellulose and I was able to provide insights into the interplay between this material and a series of biological systems. More specifically, bacterial nanocellulose was evaluated in several application contexts such as cellular therapies, ocular surface healing and hernia repair always in close collaboration with relevant players in the respective disciplines.
University: Universitat Autònoma de Barcelona (UAB)
PhD Programme: Materials Science